Elastimed Ltd has been awarded an SME Instrument Phase 2 grant of €1.3 million under grant agreement No. 812092.
ComFyt, the revolution in compression therapy. A novel Electro-Active Polymers technology applied to a smart stocking that mimics rhythmic calf muscle contractions and stimulates the blood flow.
In the two years of the “ComFyt” project, Elastimed’s smart compression device will be complete its development, industrialized and demonstrated through a clinical study in Europe.
The SME Instrument is a programme under the Horizon 2020 framework run by the EASME, the European Executive Agency for Small and Medium-sized Enterprises.
The innovation consists in the proprietary method and mechanism for maintaining the smart material- Electroactive Polymers (EAP) – in a pre-stretch state. This revolutionary technology manipulates the EAP film into thin, linear actuators, for integration in numerous healthcare devices. Highly suitable for wearable devices, the EAPs expand and contract when stimulated by an electric field. ComFyt – the first application of our innovation – is a smart stocking designed for venous disease patients. ComFyt can be worn throughout the day everywhere. It massages the leg mimicking calf muscle contractions and treating potentially life threatening circulatory conditions. Its agility and flexibility solves the problem of low compliance and comfort of the current compression therapy devices. Blood circulation is a crucial part of the human anatomy, ensuring nutrient and oxygen delivery to all the cells in the body. Poor circulation can cause painful venous diseases, such as edema, varicose veins, lymphedema, and multiple sports injuries, which greatly affect the patient’s quality of life. Life threatening disorders, such as Chronic Venous Insufficiency and Deep Vein Thrombosis (DVT) are serious conditions caused by compromised circulation too. Every year, approximately 10 million people suffer from DVT worldwide.